Header Logo

Connection

MARA B ANTONOFF to Cisplatin

Back to Details
This is a "connection" page, showing publications MARA B ANTONOFF has written about Cisplatin.
MARA B ANTONOFF
Connection Strength
0.026
Cisplatin
  1. A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer. Clin Cancer Res. 2020 07 15; 26(14):3525-3536.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.